trending Market Intelligence /marketintelligence/en/news-insights/trending/V2kwkLWIVSFkRzgRjfYLgw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Diagnos seeks to restructure its debt, implement 1-for-10 reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Diagnos seeks to restructure its debt, implement 1-for-10 reverse stock split

Diagnos Inc. plans to reorganize its debt and capital structure and has proposed an amendment to its 10% secured convertible debentures along with a 1-for-10 reverse stock split.

Under the proposed amendment, Diagnos will offer holders of its 10% secured convertible debentures about C$4.9 million in common shares at 3.5 Canadian cents apiece.

The company will seek approval for the amendment from the holders of the debentures in a meeting scheduled for April 4. After gaining their approval, the company plans to seek further conversion of debentures worth C$1 million into common shares at the same price.

The Brossard, Quebec-based ophthalmological diagnostics company will conduct a special meeting with its shareholders April 10 to seek their approval for the share consolidation.

The amendment, repayment and conversion of debentures are subject to approval from TSX Venture Exchange and can only be completed after the company gets shareholder approval for the reverse stock split to meet the exchange's requirement of 5 cents minimum share issuance price.